| Literature DB >> 16759117 |
Christophe Dardonville1, Michael P Barrett, Reto Brun, Marcel Kaiser, Farial Tanious, W David Wilson.
Abstract
A new antitrypanosomal hit compound that cures an acute (STIB 900) mouse model of Trypanosoma brucei rhodesiense trypanosomiasis is described. This bis(2-aminoimidazolinium) dicationic compound proved to be an excellent DNA minor groove binder, suggesting a possible mechanism for its trypanocidal activity. From these studies, the 4,4'-diaminodiphenylamine skeleton emerged as a good scaffold for antitrypanosomal drugs.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16759117 DOI: 10.1021/jm060295c
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446